Haemonetics (HAE) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $73.17 -1.35%
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.38
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.38
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $346 million versus the consensus estimate of $337.04 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Chevron, Microsoft strike 20-year deal to power massive AI data center
- Ruanyun Edai Technology (RYET) files for 20M share offering by selling stockholders
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
